Robert A. Jolly
Senior Advisor
Robert A. Jolly graduated with a degree in pharmacology and toxicology from the University of Wisconsin, Madison. He later received a CPH and an MPH in Environmental Science from the University of Indiana. Bob has worked in the field of Toxicology for over thirty years starting his career in investigative toxicology and moving to human health risk assessment toxicologist in 2010. He is currently a Senior Advisor in the Toxicology group at Eli Lilly and Company where he has worked since 2002. He is a “Diplomate of the American Board of Toxicology (DABT)” with certification since 2012. Bob has coauthored over 50 peer reviewed publications and most recently has published several manuscripts on the toxicology of nitrosamines.
DAY 1: December 2nd, 2026
SESSION: Qualification of Impurities in Drug Substances and Drug Products
◆ Setting limits for impurities in Development, normal and genotoxic.
◆ Predicting nitrosamine formation.
◆ Challenges in setting limits for nitrosamines.
